MedTrace Logo

Oral Prednisolone in the Treatment of Esophageal Stricture After Esophageal Surgery

NCT02703376 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2016-03-09

No results posted yet for this study

Summary

This study is safety and proof-of-concept study for oral prednisolone in the treatment of esophageal stricture after esophageal surgery. The patients who develop the severe esophageal strictures from 28 days after esophageal surgery are included. Primary outcomes are Safety and Success rate of this treatment.

Conditions

  • Esophageal Anastomotic Stricture

Interventions

DRUG

Oral Prednisone

Intakes of Oral Prednisone for 12 weeks after balloon dilations

Sponsors & Collaborators

  • Nagasaki University

    lead OTHER

Principal Investigators

  • Kobayashi Shinichiro · Department of Surgery Nagasaki University Graduate School of Biomedical Sciences

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-03-31
Completion
2019-10-31

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02703376 on ClinicalTrials.gov